Trademark: 88882830
Word
SENBEXUS
Status
Pending
Status Code
734
Status Date
Wednesday, January 31, 2024
Serial Number
88882830
Mark Type
4000
Filing Date
Wednesday, April 22, 2020
Published for Opposition
Tuesday, June 8, 2021

Trademark Owner History
Celgene Corporation - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use

Trademark Events
Feb 1, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 31, 2024
Sou Extension 5 Granted
Jan 12, 2024
Sou Extension 5 Filed
Jan 30, 2024
Case Assigned To Intent To Use Paralegal
Jan 12, 2024
Sou Teas Extension Received
Aug 4, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 2, 2023
Sou Extension 4 Granted
Aug 2, 2023
Sou Extension 4 Filed
Aug 2, 2023
Sou Teas Extension Received
Feb 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 31, 2023
Sou Extension 3 Granted
Jan 31, 2023
Sou Extension 3 Filed
Jan 31, 2023
Sou Teas Extension Received
Jul 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 27, 2022
Sou Extension 2 Granted
Jul 27, 2022
Sou Extension 2 Filed
Jul 27, 2022
Sou Teas Extension Received
Feb 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 2, 2022
Sou Extension 1 Granted
Feb 2, 2022
Sou Extension 1 Filed
Feb 2, 2022
Sou Teas Extension Received
Aug 3, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 8, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 8, 2021
Published For Opposition
May 19, 2021
Notification Of Notice Of Publication E-Mailed
May 5, 2021
Approved For Pub - Principal Register
May 4, 2021
Teas/Email Correspondence Entered
May 4, 2021
Correspondence Received In Law Office
May 3, 2021
Assigned To Lie
Jan 20, 2021
Notice Of Revival - E-Mailed
Jan 19, 2021
Teas Response To Office Action Received
Jan 19, 2021
Petition To Revive-Granted
Jan 19, 2021
Teas Petition To Revive Received
Jan 12, 2021
Assigned To Examiner
Jan 11, 2021
Teas/Email Correspondence Entered
Jan 11, 2021
Correspondence Received In Law Office
Jan 11, 2021
Teas Response To Office Action Received
Jul 14, 2020
Notification Of Non-Final Action E-Mailed
Jul 14, 2020
Non-Final Action E-Mailed
Jul 14, 2020
Non-Final Action Written
Jul 13, 2020
Assigned To Examiner
May 1, 2020
New Application Office Supplied Data Entered
Apr 25, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24